These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 30548045)

  • 1. CRISPR/Cas-based genome engineering in natural product discovery.
    Tong Y; Weber T; Lee SY
    Nat Prod Rep; 2019 Sep; 36(9):1262-1280. PubMed ID: 30548045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Efficiency Genome Editing of Streptomyces Species by an Engineered CRISPR/Cas System.
    Wang Y; Cobb RE; Zhao H
    Methods Enzymol; 2016; 575():271-84. PubMed ID: 27417933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules.
    Singh R; Chandel S; Ghosh A; Dey D; Chakravarti R; Roy S; Ravichandiran V; Ghosh D
    Mol Biotechnol; 2021 Jun; 63(6):459-476. PubMed ID: 33774733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the promise and limitations of CRISPR/Cas system in natural product research: Approaches and challenges.
    Biswas P; Anand U; Ghorai M; Pandey DK; Jha NK; Behl T; Kumar M; Chauhan R; Shekhawat MS; Dey A
    Biotechnol J; 2022 Jul; 17(7):e2100507. PubMed ID: 34882991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas system for yeast genome engineering: advances and applications.
    Stovicek V; Holkenbrink C; Borodina I
    FEMS Yeast Res; 2017 Aug; 17(5):. PubMed ID: 28505256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-aided genome engineering for secondary metabolite biosynthesis in Streptomyces.
    Lee Y; Hwang S; Kim W; Kim JH; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2024 Jan; 51():. PubMed ID: 38439699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas 9-Based Editing in the Production of Bioactive Molecules.
    Bhagwat AC; Patil AM; Saroj SD
    Mol Biotechnol; 2022 Mar; 64(3):245-251. PubMed ID: 34643870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current situation of biofuel production and its enhancement by CRISPR/Cas9-mediated genome engineering of microbial cells.
    Javed MR; Noman M; Shahid M; Ahmed T; Khurshid M; Rashid MH; Ismail M; Sadaf M; Khan F
    Microbiol Res; 2019 Feb; 219():1-11. PubMed ID: 30642460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-based metabolic editing: Next-generation metabolic engineering in plants.
    Sabzehzari M; Zeinali M; Naghavi MR
    Gene; 2020 Oct; 759():144993. PubMed ID: 32717311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
    Mitsui R; Yamada R; Ogino H
    World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli.
    Hashemi A
    World J Microbiol Biotechnol; 2020 Jun; 36(7):96. PubMed ID: 32583135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. System-level genome editing in microbes.
    Csörgő B; Nyerges Á; Pósfai G; Fehér T
    Curr Opin Microbiol; 2016 Oct; 33():113-122. PubMed ID: 27472027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.